ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00537524
Recruitment Status : Completed
First Posted : October 1, 2007
Last Update Posted : February 16, 2012
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Vaccines )